4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-17-065247
Director acquired 10,756,249 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT Director | 2017-12-12 | Conversion | +10,756,249 | 11,068,749 | I | ||
| Derivatives | |||||||
| NELSEN ROBERT Director | 2017-12-12 | Conversion · Series A-1 Preferred Stock | −10,068,749 | 0 | I | ||
| NELSEN ROBERT Director | 2017-12-12 | Conversion · Series A-2 Preferred Stock | −375,000 | 0 | I | ||
| NELSEN ROBERT Director | 2017-12-12 | Conversion · Series B-1 Preferred Stock | −312,500 | 0 | I | ||
Loading xslF345X03/doc4.xml…